CHILDHOOD SOLID TUMOR PROGRAM

The solid tumor program at Connecticut Children’s Medical Center provides state of the art, comprehensive clinical care for children with cancers of the bone, soft tissue, abdomen, among other areas. The program comprises a multidisciplinary team of experts (including oncologist, radiation oncologist, surgeons, radiologist, pathologists, psychosocial providers, and nurses) who collaborate in the care of each child in an effort to provide unsurpassed cancer therapies to our patients.

Connecticut Children’s solid tumor team has developed a special expertise in providing unprecedented care coordination, and dedication to timely, rapid, and seamless response following a child’s initial diagnosis.

The solid tumor team at Connecticut Children’s Medical Center has been recognized nationally on numerous clinical and basic science research efforts. They participate on regional and national committees through the efforts of the National Cancer Institute-sponsored Children’s Oncology Group to develop novel therapies for the children with solid tumor malignancies.

The solid tumor team has specific interests and expertise in caring for children with many of the following malignancies listed below. We strive to making early and accurate diagnosis, and coordinating appropriate and individualized treatment regimens.

Rhabdomyosarcoma
Non-Rhabdomatous Sarcomas
Neuroblastoma
Wilms Tumor
Germ Cell Tumor
Retinoblastoma
Ewings Sarcoma and related tumors
Osteosarcoma
Hepatoblastoma

The care of children with cancer has dramatically improved over the course of last 30 years. This has primarily been attributed to the national clinical trials and development of novel therapeutics. We are one of many nationally recognized children’s hospitals that participate and develop clinical trials through the efforts of Children’s Oncology Group. The currently ongoing clinical trials for solid tumors available at Connecticut Children’s Medical Center are: